SEI Investments Portfolio holdings
AUM
$86.3B
1-Year Return
22.26%
This Quarter Return
-1.7%
1 Year Return
+22.26%
3 Year Return
+83.74%
5 Year Return
+138.48%
10 Year Return
+342.87%
AUM
$77.7B
AUM Growth
-$171M
(-0.22%)
Cap. Flow
+$2.62B
Cap. Flow
% of AUM
3.37%
Top 10 Holdings %
Top 10 Hldgs %
17.15%
Holding
2,883
New
162
Increased
1,461
Reduced
942
Closed
126
Top Buys
| 1 |
Visa
V
|
+$188M |
| 2 |
Eli Lilly
LLY
|
+$121M |
| 3 |
Broadcom
AVGO
|
+$120M |
| 4 |
Vanguard Total Stock Market ETF
VTI
|
+$114M |
| 5 |
Baker Hughes
BKR
|
+$98M |
Top Sells
| 1 |
Arthur J. Gallagher & Co
AJG
|
+$123M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$79.8M |
| 3 |
Automatic Data Processing
ADP
|
+$78.2M |
| 4 |
Eaton
ETN
|
+$74M |
| 5 |
Quanta Services
PWR
|
+$73M |
Sector Composition
| 1 | Technology | 19.67% |
| 2 | Financials | 11.1% |
| 3 | Healthcare | 9.08% |
| 4 | Consumer Discretionary | 8.63% |
| 5 | Industrials | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2601
ThredUp
TDUP
$1.37B
| $52.1K | ﹤0.01% |
21,636
| – | – |
|
2602
Dynagas LNG Partners
DLNG
$141M
| $51.9K | ﹤0.01% |
13,765
| – | – |
|
2603
RAPT Therapeutics
RAPT
$220M
| $49.1K | ﹤0.01% |
5,027
| – | – |
|
2604
OmniAb
OABI
$229M
| $49K | ﹤0.01% |
20,402
-23,084
| -53% | -$55.4K |
|
2605
Solid Biosciences
SLDB
$389M
| $48.4K | ﹤0.01% |
13,078
| – | – |
|
2606
Kyverna Therapeutics
KYTX
$169M
| $47.6K | ﹤0.01% |
+24,660
| New | +$47.6K |
|
2607
8x8 Inc
EGHT
$285M
| $47K | ﹤0.01% |
23,491
+1,511
| +7% | +$3.02K |
|
2608
AC Immune
ACIU
$221M
| $46.6K | ﹤0.01% |
+24,897
| New | +$46.6K |
|
2609
PLAYSTUDIOS Inc
MYPS
$121M
| $45.1K | ﹤0.01% |
35,484
-29
| -0.1% | -$37 |
|
2610
James River Group
JRVR
$247M
| $44.9K | ﹤0.01% |
10,692
| – | – |
|
2611
Orchestra BioMed
OBIO
$147M
| $44K | ﹤0.01% |
10,290
| – | – |
|
2612
MacroGenics
MGNX
$111M
| $43.2K | ﹤0.01% |
+34,016
| New | +$43.2K |
|
2613
Clean Energy Fuels
CLNE
$539M
| $42.7K | ﹤0.01% |
27,556
| – | – |
|
2614
Ocugen
OCGN
$322M
| $42.4K | ﹤0.01% |
59,981
| – | – |
|
2615
Nkarta
NKTX
$151M
| $41.9K | ﹤0.01% |
22,788
| – | – |
|
2616
Destination XL Group
DXLG
$69.5M
| $41.3K | ﹤0.01% |
28,271
| – | – |
|
2617
Ventyx Biosciences
VTYX
$170M
| $41.1K | ﹤0.01% |
35,764
| – | – |
|
2618
Hertz
HTZ
$1.89B
| $41K | ﹤0.01% |
10,412
-31
| -0.3% | -$122 |
|
2619
Tenaya Therapeutics
TNYA
$212M
| $39.7K | ﹤0.01% |
69,702
| – | – |
|
2620
Quantum-Si Incorporated
QSI
$233M
| $39.7K | ﹤0.01% |
33,103
| – | – |
|
2621
FibroGen
FGEN
$45.1M
| $39.3K | ﹤0.01% |
5,070
| – | – |
|
2622
Aclaris Therapeutics
ACRS
$231M
| $38.5K | ﹤0.01% |
+25,189
| New | +$38.5K |
|
2623
ALX Oncology
ALXO
$59.4M
| $37.9K | ﹤0.01% |
60,795
| – | – |
|
2624
Metagenomi
MGX
$69.8M
| $37.7K | ﹤0.01% |
27,751
| – | – |
|
|
ONL
2625
Orion Office REIT
ONL
$171M
| $37.3K | ﹤0.01% |
17,470
| – | – |
|